GLAUCOMA

This study looks at which type of patch works best in glaucoma surgery to lower eye pressure. Researchers will compare three materials (donor sclera, cornea, and pericardium) in 180 adults having a PreserFlo MicroShunt procedure. The goal is to find the patch that leads to fewer …

This study tests whether a structured education program helps glaucoma patients in Nepal follow their treatment better. Glaucoma requires lifelong care to prevent blindness, but many patients struggle with adherence. Researchers will measure changes in adherence using a questionn…

This study tests a laser treatment called DSLT in 40 Asian adults with normal tension glaucoma, a type of glaucoma where eye pressure is not very high. The goal is to see if the laser can lower eye pressure and reduce the number of daily eye drops needed. Participants will have r…

This study tests if a special temporary stitch placed inside a new glaucoma drainage device (Preserflo) can lower the risk of dangerously low eye pressure after surgery. The trial will include 192 adults with glaucoma who need surgery. The goal is to see if this simple change mak…

This study looks at people with mild to moderate glaucoma who need multiple eye drops. After a laser procedure to help drain fluid, half will get a combination drop (netarsudil and latanoprost) and half will get a standard drop (latanoprost alone). The goal is to see which plan l…

This study will develop an artificial intelligence (AI) system to detect major eye diseases like glaucoma, cataracts, and diabetic retinopathy. Researchers will use 15,000 existing eye images from Costa Rican patients to train and test the AI. The goal is to create a tool that wo…

This study will test an artificial intelligence (AI) system that reads eye scans (OCT) to diagnose common blinding eye diseases like diabetic retinopathy, macular degeneration, and glaucoma. Researchers will collect 2,000 real-world scans and see how well the AI can identify each…

This study tests if a structured blinking exercise can reduce dry eye symptoms in adults with glaucoma who use daily eye drops. Over two weeks, participants will do special blink cycles three times a day. Researchers will measure symptom relief and tear film health, comparing gla…

This study looks at whether Lumify, a mild eye drop already approved for redness, can safely reduce eye redness in 60 glaucoma patients who are already using stronger brimonidine drops. Researchers will check redness, eye pressure, and eyelid position. The goal is to see if Lumif…

This study tests a device called the Nanodropper that helps people with glaucoma put eye drops in their eyes more easily. Many patients have trouble squeezing the bottle or seeing clearly, which leads to wasted medication. The study will see if the device helps patients use their…

This small pilot study tests whether a safe, non-invasive brain stimulation can temporarily improve orientation and mobility in adults with tunnel vision from conditions like retinitis pigmentosa or glaucoma. Twenty participants will complete an obstacle course after receiving ei…

This study will screen over 7,000 adults aged 40 and older living in affordable housing in New York City for undiagnosed or uncontrolled high blood pressure and glaucoma. Participants will receive free screenings and be referred to follow-up care. The goal is to see if a virtual …

This study looks at whether a common type of glaucoma eye drop (prostaglandin analogues) can protect the nerve cells in the back of the eye, beyond just lowering eye pressure. Researchers will review medical records from 1500 adults with glaucoma over 3 years. They will compare t…

This study looks at how Rocklatan eye drops change blood flow in the eyes of 30 people with early glaucoma. Researchers will use special cameras to measure blood flow before and after using the drops for up to a year. The goal is to better understand the drug's effects, not to tr…

This study looks at how Rhopressa eye drops change the drainage tissue inside the eye in people with glaucoma or high eye pressure. About 50 adults will be randomly assigned to get either Rhopressa or placebo (artificial tears) for two weeks. Researchers will use special cameras …

This study looks at how the optic nerve changes when eye pressure is lowered in people who do not have glaucoma. Researchers will take pictures of the optic nerve before and after using a daily glaucoma eye drop for two weeks. The goal is to compare these results with those from …

This study looks at whether a home-based exercise program (resistance training and stationary cycling) can protect or improve vision in people with glaucoma, a disease that damages eye nerves. Researchers will measure changes in vision, eye blood flow, and quality of life in 150 …